PYRAZINE PROTEASE INHIBITORE
European patent · EP1086122 · Deleted
Register entry
- Publication number
- EP1086122
- Application number
- EP99928582
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jun 11, 1999
- Published
- Mar 28, 2001
- Granted
- Aug 24, 2005
- Deleted
- Jun 30, 2008
- Reason
- Annual fee unpaid
- IPC classes
- C07K 5/078 (2006.01)A61K 38/05 (2006.01)G01N 33/68 (2006.01)
- Priority
- US 88989 P 11.06.1998
- PCT application
- PCT/US1999/013228 11.06.1999
- PCT publication
- WO1999/064446 16.12.1999
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 21, 2009
Deleted, fee unpaid
Published in Swissreg on 21.01.2009
- Jan 31, 2007
Transferred
- Owner
- Johnson & Johnson Pharmaceutical Research &, Development, L.L.C., 920 US Route 202, Raritan, New Jersey 08869, USA → Ortho-McNeil Pharmaceutical, Inc., US Route 202 South,, Raritan, NJ 08869, USA
Published in +pat+ No 2 in 2007
- Nov 30, 2005
Agent entered
- Representative
- Dr. Joachim Lauer, Patentanwalt, Stapferstrasse 5,, Postfach 2651, 8033 Zürich
Published in +pat+ No 22 in 2005
- Aug 31, 2005
Granted
Published in +pat+ No 16 in 2005
Parties
Inventor
LU, Tianbao
Collegeville, PA 19426, US
TOMCZUK, Bruce, E.
Collegeville, PA 19426, US
MARKOTAN, Thomas, P.
Morgantown, PA 19543, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.